CGON vs CI · rev $4.0M vs P/E 2.4, rev $140.16B
CG Oncology, Inc. Common stock (CGON) versus Cigna Corp (CI) — a side-by-side from cached financials, not a winner call.
CG Oncology, Inc. Common stock (CGON) is a biotechnology company listed on US.
Cigna Corp (CI) is a healthcare plans company listed on US.
Latest reported CGON revenue for 2025-12-31 was $4.0M. Net income was -$161.0M. Revenue was up 254.7% from 2024-12-31 to 2025-12-31. CGON currently screens at market cap $4.74B.
Latest reported CI revenue for 2026-06-30 was $140.16B. Net income was $3.31B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
CGON currently screens at market cap $4.74B. CI currently screens at market cap $71.62B and trailing P/E 2.4.
Not investment advice. Open the CGON and CI stock pages for the full models.
Not investment advice.